GENTILE, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 3.849
EU - Europa 1.185
AS - Asia 627
AF - Africa 33
SA - Sud America 29
OC - Oceania 6
Totale 5.729
Nazione #
US - Stati Uniti d'America 3.820
IT - Italia 485
SG - Singapore 241
IN - India 175
CN - Cina 155
SE - Svezia 144
IE - Irlanda 116
UA - Ucraina 87
FI - Finlandia 82
DE - Germania 77
GB - Regno Unito 44
CA - Canada 26
NL - Olanda 24
TG - Togo 23
FR - Francia 22
AR - Argentina 19
ID - Indonesia 19
BG - Bulgaria 16
BE - Belgio 14
RU - Federazione Russa 13
AT - Austria 11
RO - Romania 11
ES - Italia 8
IL - Israele 8
JP - Giappone 8
BR - Brasile 5
SC - Seychelles 5
AU - Australia 4
CH - Svizzera 4
CL - Cile 4
PK - Pakistan 4
GR - Grecia 3
HK - Hong Kong 3
HU - Ungheria 3
IR - Iran 3
LT - Lituania 3
MX - Messico 3
PT - Portogallo 3
TH - Thailandia 3
AL - Albania 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
KR - Corea 2
MK - Macedonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
TR - Turchia 2
AZ - Azerbaigian 1
BJ - Benin 1
CO - Colombia 1
CY - Cipro 1
HR - Croazia 1
LV - Lettonia 1
MU - Mauritius 1
NO - Norvegia 1
PL - Polonia 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 5.729
Città #
Fairfield 564
Chandler 369
Ashburn 309
Woodbridge 283
Houston 243
Seattle 227
Wilmington 207
Cambridge 199
Ann Arbor 181
Rome 177
Singapore 163
Dublin 113
Santa Clara 90
Princeton 89
Dearborn 87
San Paolo di Civitate 86
Plano 72
Lawrence 63
Beijing 62
New York 60
San Diego 43
Millbury 38
Boston 37
Fremont 34
Jacksonville 31
Norwalk 29
Andover 27
Lomé 23
Federal 19
Jakarta 19
Nanjing 18
Des Moines 17
Sofia 16
Toronto 16
Bremen 15
Boardman 14
Helsinki 14
Brussels 12
Vienna 11
Bühl 10
Milan 9
Naples 9
Shanghai 9
Falls Church 8
Moscow 8
Amsterdam 7
Kunming 7
Ottawa 7
Roseto Degli Abruzzi 7
Brescia 6
Falkenstein 6
Hefei 6
Jerusalem 6
Los Angeles 6
San Mateo 6
Bologna 5
Frankfurt am Main 5
Guangzhou 5
Phoenix 5
Redwood City 5
Auburn Hills 4
Fuzhou 4
Grafing 4
Gravina in Puglia 4
Indiana 4
Jiaxing 4
London 4
Mahé 4
Napoli 4
Paris 4
Redmond 4
San Jose 4
Athens 3
Bari 3
Budapest 3
Chengdu 3
Fasano 3
Florence 3
Fuenlabrada 3
Guimarães 3
Jinan 3
Kumamoto 3
Latina 3
Mexico City 3
Munich 3
Nagercoil 3
Philadelphia 3
Pune 3
Sargodha 3
Torri di Quartesolo 3
Auckland 2
Bengaluru 2
Bolzano 2
Castenaso 2
Changsha 2
Chiang Mai 2
Chongqing 2
Delhi 2
Ercolano 2
Falakata 2
Totale 4.341
Nome #
Mitochondrial myopathy and comorbid major depressive disorder. effectiveness of dTMS on gait and mood symptoms 127
1: Esculentin-1b(1-18) - a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli. 115
An integrated analysis of the effects of Esculentin 1-21 on Saccharomyces cerevisiae 106
Potential role of single nucleotide polymorphisms of XRCC1, XRCC3, and RAD51 in predicting acute toxicity in rectal cancer patients treated with preoperative radiochemotherapy 106
Genotype–phenotype correlations in 5-fluorouracil metabolism. a candidate DPYD haplotype to improve toxicity prediction 105
Personalized medicine applied to forensic sciences: new advances and perspectives for a tailored forensic approach 102
Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes 101
Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin 100
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker? 99
Choosing the safest acute therapy during chronic migraine prophylactic treatment. pharmacokinetic and pharmacodynamic considerations 93
Pharmacogenetic considerations for migraine therapies 92
WT1 CpG islands methylation in human lung cancer: A pilot study 90
Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine 88
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX 88
Investigating biochemical models' background: the proteomic approach for bovine brain capillaries properties assessement 87
Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation 87
Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes. A Long-Term Follow-up Study 87
Precise medical decision making in geriatric anti-depressant therapy 86
The Italian Diabetes and Exercise Study (IDES): Design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome 85
Development of Asymptomatic Pancreatitis With Paradoxically High Serum Clozapine Levels in a Patient With Schizophrenia and the CYP1A2*1F/1F Genotype 84
Lack of association between oxidative stress-related gene polymorphisms and chronic migraine in an Italian population 84
Eletriptan in the management of acute migraine. An update on the evidence for efficacy, safety, and consistent response 83
Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine 83
Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study 83
Single nucleotide polymorphisms related to vitamin B12 serum levels in autoimmune gastritis patients with or without pernicious anaemia 82
Intramuscular Aripiprazole in the Acute Management of Psychomotor Agitation 82
Severe and prolonged myelosuppression during concomitant temozolomide and radiotherapy treatment in a patient with glioblastoma multiforme 82
Effect of MTHFR polymorphisms on gastrointestinal cancer risk in Italy 79
Proteomic characterization of Jurkat T leukemic cells after dopamine stimulation: A model of circulating dopamine-sensitive cells 79
Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer 78
Emerging treatment for chronic migraine and refractory chronic migraine 78
Pre-treatment evaluation of 5-fluorouracil degradation rate. association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort 78
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 78
Effects of a Membrane-Active Amphibian Antimicrobial Peptide on the Bacterial Proteome 76
Pharmacogenetic assessment of toxicity in patients treated with taxane-based chemotherapy for solid tumors 76
A proteomic strategy in the diagnosis of cryoglobulins. 76
Lasmiditan for the treatment of migraine 76
Ribavirin transporter [Ent1] polymorphism is a pretreatment predictor of virologic response. the specific role of donor liver transporter 75
Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy 75
A liquid chromatography-tandem mass spectrometry method for the determination of 5-fluorouracil degradation rate by intact peripheral blood mononuclear cells 74
Genetic association analysis of serotonin and signal transduction pathways in suicide attempters from an Italian sample of psychiatric patients 73
Urinary concentration of 8-isoprostane as marker of severity of pediatric OSAS 72
Proteomic profiles in hyperandrogenic syndromes 72
Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotane 69
Personalized cancer therapy considering cytochrome P450 variability 68
One-Carbon Metabolism Alteration Affects Brain Proteome Profile in a Mouse Model of Alzheimer's Disease 68
Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine 65
Personalised healthcare: the DiMA clinical model 65
Neutrophil gelatinase-associated lipocalin levels after use of mini-cardiopulmonary bypass system. 62
null 61
Specific effects exerted by B-lymphoproliferative diseases on peripheral T-lymphocyte protein expression 61
null 60
Proteomic analysis of TgCRND8 mice brain in condition of altered one-carbon metabolism. 59
Novel insights into phenotype and mitochondrial proteome of yeast mutants lacking proteins Sco1p or Sco2p 57
null 57
Stable Remission of Multiple Chemical Sensitivity Syndrome and Major Depression With Citalopram and 1-Month Deep Transcranial Magnetic Stimulation. A Case Report 56
The SNPs in the human genetic blueprint era 54
Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine 54
Genetics of Obstructive Sleep Apnea. Vitamin D Receptor Gene Variation Affects Both Vitamin D Serum Concentration and Disease Susceptibility 54
PON1 polymorphisms can predict generalized anxiety and depressed mood in patients with multiple chemical sensitivity 53
Single nucleotide polymorphism of gstp1 and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy 52
Individualized drugs’ selection by evaluation of drug properties, pharmacogenomics and clinical parameters. Performance of a bioinformatic tool compared to a clinically established counselling process 50
Proteomic analysis of peripheral T lymphocytes, suitable circulating biosensors of strictly related diseases 49
Analysis of short term and stable DNA damage in patients with differentiated thyroid cancer treated with 131I in hypothyroidism or with rhTSH for remnant ablation 48
Multiple chemical sensitivity syndrome. A principal component analysis of symptoms 47
Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders 45
Vitamin D Receptor ApaI a Allele Is Associated with Better Childhood Asthma Control and Improvement in Ability for Daily Activities. 43
Gene polymorphism Analysis by Pyrosequencing in NSCLCpatients treated With Cisplatin-Based Chemotherapy. 42
Validation of a small-size pooling approach targeting hospital surveillance of SARS-CoV-2 infection 42
The impact of drug–drug Interactions on the toxicity profile of combined treatment with BRAF and MEK Inhibitors in patients with BRAF-mutated metastatic melanoma 41
Are Bv8-like molecules involved in innate immunity? 41
SPECIFIC EFFECTS EXERTED BY B-LYMPHOPROLIFERATIVE DISEASES ON PERIPHERAL TLYMPHOCYTES PROTEIN EXPRESSION 40
The future of pharmacogenetics in the treatment of migraine 40
Machine Learning and Pharmacogenomics at the Time of Precision Psychiatry 39
PROTEOMIC STUDY OF PAN T CELLS IN PATIENTS AFFECTED BY POLYCYSTIC OVARY SINDROME 39
GENOMIC AND PROTEOMIC ANALYSIS OF CD8+ TCELL SUBSETS IN MONOZYGOTIC TWIN PAIRS DISCORDING FOR MULTIPLE SCLEROSIS. 39
Serum proteome analysis in patients of the italian diabetes and exercise survey (IDES) study. 38
Fc gamma R and FGFR4 polymorphisms associated with the pathological complete response (pCR) to trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer 36
DRD2, DRD3, and HTR2A Single-Nucleotide Polymorphisms Involvement in High Treatment Resistance to Atypical Antipsychotic Drugs 35
The omics in migraine 35
ANALYSIS OF S. CEREVISIAE RESPONSE TO DIFFERENT ANTIMICROBIAL PEPTIDES 35
Evidence-based considerations exploring relations between sars-cov-2 pandemic and air pollution: Involvement of pm2.5-mediated up-regulation of the viral receptor ace-2 34
COMPARATIVE PROTEOMIC ANALYSIS OF CSF FROM PATIENTS AFFECTED BY NEURODEGENERATIVE DISEASES 33
EFFECT OF DEGRADATION RATE OF 5-FU AND GENETIC POLYMORPHISMS OF DPD, TSER AND MTHRF ON TOXICITY AND SURVIVAL OF 5-FU-BASED CHEMOTHERAPY IN GASTRIC CANCER 33
Effect of Degradation Rate of 5-FU and Genetic Polymorphisms of DPYD, TSER and MTHFR on Toxicity and Survival of 5-FU-based Chemotherapy in Metastatic Colorectal Cancer. 33
Pharmacogenetic insights into migraine treatment in children. 29
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer 29
Is the Hedgehog Pathway Involved in the Pathophysiology of Schizophrenia? A Systematic Review of Current Evidence of Neural Molecular Correlates and Perspectives on Drug Development 27
FcγR and FGFR4 polymorphisms related to Progression Free Survival in metastatic breast cancer patients treated with trastuzumab-based therapy 24
Recognizing and preventing unacknowledged prescribing errors associated with polypharmacy 23
Opinion paper on the systematic application of integrated bioinformatic tools to actuate routine precision medicine in poly-treated patients 21
null 20
Detection of α-defensin in synovial fluids by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry as an innovative and cost-effective assay for improved definition of periprosthetic joint infections 20
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value? 19
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy 19
Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity. Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays 18
Age-Related Dynamics of Serum Anti-Spike IgG Ab After the Third Dose of BNT162b2 Vaccine in a Naive Health Care Workers Population 15
Frequencies of Combined Dysfunction of Cytochromes P450 2C9, 2C19, and 2D6 in an Italian Cohort. Suggestions for a More Appropriate Medication Prescribing Process 15
Detection of α-defensin in synovial fluids by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry as an innovative and cost-effective assay for improved definition of periprosthetic joint infections 12
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value? 7
Totale 6.052
Categoria #
all - tutte 18.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020829 0 0 0 0 0 189 178 145 128 98 52 39
2020/2021430 48 42 24 32 27 43 8 33 40 78 36 19
2021/2022987 10 76 99 38 114 35 33 85 88 71 166 172
2022/20231.231 177 224 66 153 189 133 30 74 121 19 30 15
2023/2024595 34 75 44 50 44 84 19 63 5 63 58 56
2024/2025457 32 87 75 70 103 90 0 0 0 0 0 0
Totale 6.052